Long-Term Outcomes of Brain Radiotherapy Plus Camrelizumab and Chemotherapy in Untreated NSCLC With Brain Metastases (C-Brain)

pemetrexed - Generic mfg.

AiRuiKa (camrelizumab) - Elevar Therapeutics

Y. Fan1,2; Y. Xu2; H. Li2; Z. Huang2; H. Lu2; K. Chen2; S. Yu2; N. Han2; L. Gong2; J. Qin2; F. Xie2; D. Huang3; J. Chen4; C. Gu2

Jul 31, 2026